WGU D398 INTRODUCTION TO
PHARMACOLOGY OBJECTIVE ASSESSMENTS
(OA V1, V2 & V3) UPDATED 2026–2027 |
COMPLETE STUDY GUIDE | VERIFIED
QUESTIONS, ANSWERS & RATIONALES | ALL
OA VERSIONS | WGU PHARMACOLOGY
EXAM PREP BUNDLE
WGU D398: INTRODUCTION TO PHARMACOLOGY
OBJECTIVE ASSESSMENTS (OA V1, V2 & V3) COMPLETE STUDY GUIDE
VERIFIED QUESTIONS, ANSWERS & EXPERT RATIONALE | 2026–2027 EDITION
DOCUMENT OVERVIEW
• Comprehensive Coverage: This study guide contains verified practice questions
covering all topics tested in WGU D398 Pharmacology OA versions (V1, V2, V3)
including pharmacokinetics, pharmacodynamics, drug classifications, and
therapeutic applications across all major organ systems.
• Strategic Study Approach: Work through questions systematically, review
detailed EXPERT RATIONALE for both correct and incorrect options, identify
knowledge gaps, and use this material to reinforce foundational pharmacology
concepts essential for clinical practice.
Question 1
Which of the following best describes pharmacokinetics?
A) The study of how the body responds to drug administration at the molecular
level
B) The mechanism by which a drug produces its therapeutic effect at receptor sites
,C) The study of drug movement through the body, including absorption,
distribution, metabolism, and elimination
D) The process by which a drug is chemically altered in the liver
E) The study of adverse drug reactions and contraindications
CORRECT ANSWER: C) The study of drug movement through the body,
including absorption, distribution, metabolism, and elimination
EXPERT RATIONALE: Pharmacokinetics is the science of how the body handles
drugs—specifically the processes of absorption (how the drug enters the body),
distribution (how it reaches target tissues), metabolism (how it is broken down),
and elimination (how it leaves the body). Options A and B describe
pharmacodynamics and mechanism of action. Option D describes metabolism only,
which is one component. Option E describes adverse effects.
Question 2
What is the primary function of hepatic metabolism in pharmacokinetics?
A) To increase drug absorption from the gastrointestinal tract
B) To enhance drug distribution to target tissues
C) To convert drugs into inactive metabolites for easier elimination
D) To prevent drug-drug interactions
E) To maintain therapeutic drug levels in the bloodstream
CORRECT ANSWER: C) To convert drugs into inactive metabolites for easier
elimination
EXPERT RATIONALE: The liver is the major organ of drug metabolism. Its primary
function is to chemically transform (metabolize) drugs into metabolites that are
typically less active and more water-soluble, facilitating their elimination via urine or
bile. This process is critical for terminating drug action and preventing drug
accumulation. While metabolism may indirectly affect other parameters, converting
drugs to inactive forms for elimination is its primary function.
,Question 3
A patient has severely reduced liver function. How would this affect the
pharmacokinetics of a drug that is extensively metabolized by the liver?
A) Increased drug absorption and faster onset of action
B) Decreased drug distribution to peripheral tissues
C) Prolonged drug half-life and increased risk of toxicity
D) Enhanced drug elimination through alternative pathways
E) Improved therapeutic effect due to higher concentrations
CORRECT ANSWER: C) Prolonged drug half-life and increased risk of toxicity
EXPERT RATIONALE: In liver disease, the metabolism of hepatically-metabolized
drugs is impaired, resulting in decreased clearance of the drug from the body. This
prolongs the drug's half-life (the time it takes for the plasma concentration to be
reduced by 50%), leading to drug accumulation and increased plasma
concentrations, which significantly increases the risk of adverse effects and toxicity.
Dose adjustments are typically necessary in hepatic impairment.
Question 4
Which route of drug administration provides the most rapid onset of action?
A) Oral
B) Intramuscular
C) Intravenous
D) Subcutaneous
E) Transdermal
CORRECT ANSWER: C) Intravenous
, EXPERT RATIONALE: Intravenous (IV) administration delivers the drug directly into
the bloodstream, bypassing all absorption barriers and providing immediate and
complete bioavailability. This results in the most rapid onset of action and the
highest peak plasma concentration compared to other routes. Oral, intramuscular,
subcutaneous, and transdermal routes all require absorption into circulation first,
which delays onset of action.
Question 5
What is the definition of drug bioavailability?
A) The maximum plasma concentration a drug can achieve
B) The fraction of administered drug that reaches systemic circulation in unchanged
form
C) The time required for plasma concentration to be reduced by half
D) The volume of distribution of a drug in the body
E) The rate at which a drug is eliminated from the body
CORRECT ANSWER: B) The fraction of administered drug that reaches
systemic circulation in unchanged form
EXPERT RATIONALE: Bioavailability refers to the proportion of an administered
dose of a drug that reaches systemic circulation in active (unchanged) form. It is
expressed as a percentage and is used to compare different routes of
administration. Intravenous administration has 100% bioavailability by definition
since the drug is directly injected into the bloodstream. Other options define
maximum concentration (peak level), half-life, volume of distribution, and
elimination rate, respectively.
Question 6
A patient is prescribed an oral medication. Which factor would MOST
significantly reduce the drug's bioavailability?
PHARMACOLOGY OBJECTIVE ASSESSMENTS
(OA V1, V2 & V3) UPDATED 2026–2027 |
COMPLETE STUDY GUIDE | VERIFIED
QUESTIONS, ANSWERS & RATIONALES | ALL
OA VERSIONS | WGU PHARMACOLOGY
EXAM PREP BUNDLE
WGU D398: INTRODUCTION TO PHARMACOLOGY
OBJECTIVE ASSESSMENTS (OA V1, V2 & V3) COMPLETE STUDY GUIDE
VERIFIED QUESTIONS, ANSWERS & EXPERT RATIONALE | 2026–2027 EDITION
DOCUMENT OVERVIEW
• Comprehensive Coverage: This study guide contains verified practice questions
covering all topics tested in WGU D398 Pharmacology OA versions (V1, V2, V3)
including pharmacokinetics, pharmacodynamics, drug classifications, and
therapeutic applications across all major organ systems.
• Strategic Study Approach: Work through questions systematically, review
detailed EXPERT RATIONALE for both correct and incorrect options, identify
knowledge gaps, and use this material to reinforce foundational pharmacology
concepts essential for clinical practice.
Question 1
Which of the following best describes pharmacokinetics?
A) The study of how the body responds to drug administration at the molecular
level
B) The mechanism by which a drug produces its therapeutic effect at receptor sites
,C) The study of drug movement through the body, including absorption,
distribution, metabolism, and elimination
D) The process by which a drug is chemically altered in the liver
E) The study of adverse drug reactions and contraindications
CORRECT ANSWER: C) The study of drug movement through the body,
including absorption, distribution, metabolism, and elimination
EXPERT RATIONALE: Pharmacokinetics is the science of how the body handles
drugs—specifically the processes of absorption (how the drug enters the body),
distribution (how it reaches target tissues), metabolism (how it is broken down),
and elimination (how it leaves the body). Options A and B describe
pharmacodynamics and mechanism of action. Option D describes metabolism only,
which is one component. Option E describes adverse effects.
Question 2
What is the primary function of hepatic metabolism in pharmacokinetics?
A) To increase drug absorption from the gastrointestinal tract
B) To enhance drug distribution to target tissues
C) To convert drugs into inactive metabolites for easier elimination
D) To prevent drug-drug interactions
E) To maintain therapeutic drug levels in the bloodstream
CORRECT ANSWER: C) To convert drugs into inactive metabolites for easier
elimination
EXPERT RATIONALE: The liver is the major organ of drug metabolism. Its primary
function is to chemically transform (metabolize) drugs into metabolites that are
typically less active and more water-soluble, facilitating their elimination via urine or
bile. This process is critical for terminating drug action and preventing drug
accumulation. While metabolism may indirectly affect other parameters, converting
drugs to inactive forms for elimination is its primary function.
,Question 3
A patient has severely reduced liver function. How would this affect the
pharmacokinetics of a drug that is extensively metabolized by the liver?
A) Increased drug absorption and faster onset of action
B) Decreased drug distribution to peripheral tissues
C) Prolonged drug half-life and increased risk of toxicity
D) Enhanced drug elimination through alternative pathways
E) Improved therapeutic effect due to higher concentrations
CORRECT ANSWER: C) Prolonged drug half-life and increased risk of toxicity
EXPERT RATIONALE: In liver disease, the metabolism of hepatically-metabolized
drugs is impaired, resulting in decreased clearance of the drug from the body. This
prolongs the drug's half-life (the time it takes for the plasma concentration to be
reduced by 50%), leading to drug accumulation and increased plasma
concentrations, which significantly increases the risk of adverse effects and toxicity.
Dose adjustments are typically necessary in hepatic impairment.
Question 4
Which route of drug administration provides the most rapid onset of action?
A) Oral
B) Intramuscular
C) Intravenous
D) Subcutaneous
E) Transdermal
CORRECT ANSWER: C) Intravenous
, EXPERT RATIONALE: Intravenous (IV) administration delivers the drug directly into
the bloodstream, bypassing all absorption barriers and providing immediate and
complete bioavailability. This results in the most rapid onset of action and the
highest peak plasma concentration compared to other routes. Oral, intramuscular,
subcutaneous, and transdermal routes all require absorption into circulation first,
which delays onset of action.
Question 5
What is the definition of drug bioavailability?
A) The maximum plasma concentration a drug can achieve
B) The fraction of administered drug that reaches systemic circulation in unchanged
form
C) The time required for plasma concentration to be reduced by half
D) The volume of distribution of a drug in the body
E) The rate at which a drug is eliminated from the body
CORRECT ANSWER: B) The fraction of administered drug that reaches
systemic circulation in unchanged form
EXPERT RATIONALE: Bioavailability refers to the proportion of an administered
dose of a drug that reaches systemic circulation in active (unchanged) form. It is
expressed as a percentage and is used to compare different routes of
administration. Intravenous administration has 100% bioavailability by definition
since the drug is directly injected into the bloodstream. Other options define
maximum concentration (peak level), half-life, volume of distribution, and
elimination rate, respectively.
Question 6
A patient is prescribed an oral medication. Which factor would MOST
significantly reduce the drug's bioavailability?
